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Abstract
Prolonged usage of antifungal azoles which target enzymes involved in lipid biosynthesis invariably leads to the
development of multi-drug resistance (MDR) in Candida albicans. We had earlier shown that membrane lipids and their
fluidity are closely linked to the MDR phenomenon. In one of our recent studies involving comparative lipidomics between
azole susceptible (AS) and azole resistant (AR) matched pair clinical isolates of C. albicans, we could not see consistent
differences in the lipid profiles of AS and AR strains because they came from different patients and so in this study, we have
used genetically related variant recovered from the same patient collected over a period of 2-years. During this time, the
levels of fluconazole (FLC) resistance of the strain increased by over 200-fold. By comparing the lipid profiles of select
isolates, we were able to observe gradual and statistically significant changes in several lipid classes, particularly in plasma
membrane microdomain specific lipids such as mannosylinositolphosphorylceramides and ergosterol, and in a mitochon-
drial specific phosphoglyceride, phosphatidyl glycerol. Superimposed with these quantitative and qualitative changes in the
lipid profiles, were simultaneous changes at the molecular lipid species levels which again coincided with the development
of resistance to FLC. Reverse transcriptase-PCR of the key genes of the lipid metabolism validated lipidomic picture. Taken
together, this study illustrates how the gradual corrective changes in Candida lipidome correspond to the development of
FLC tolerance. Our study also shows a first instance of the mitochondrial membrane dysfunction and defective cell wall (CW)
in clinical AR isolates of C. albicans, and provides evidence of a cross-talk between mitochondrial lipid homeostasis, CW
integrity and azole tolerance.
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Introduction
The phenomenon of Candida cells acquiring multidrug resistance
(MDR) is common. This however hampers their successful
chemotherapy [1–4]. The Candida species infections by and large
have been controlled by using the systemic azole drug fluconazole
(FLC), and other topical azole and polyene drugs. The excessive
use of FLC has however, resulted in the emergence of azole-
resistant strains of Candida species [5–8]. Candida albicans as well as
non-albicans species have evolved a variety of mechanisms to
develop MDR to common antifungals. Reduced intracellular
accumulation of drugs (due to rapid efflux) is one of the most
prominent mechanisms of resistance in Candida cells. Accordingly,
clinical azole resistant isolates of C. albicans display transcriptional
activation of genes, encoding ATP Binding Cassette (ABC)
multidrug transporter proteins CaCdr1p or CaCdr2p or Major
Facilitator Super family (MFS) efflux pump protein CaMdr1p [5–
8].
In C. albicans, lipids in addition to being the structural and
metabolic components of yeast cells also play an important role in
the frequently observed MDR. For example, CaCdr1p shows
selectivity towards membrane recruitment and prefers membrane
raft microdomains for its localization within plasma membrane
[9]. There are close interactions between raft constituents such as
ergosterol and sphingolipids (SLs), and disruption of these results
in altered drug susceptibilities [10,11]. Thus, any change in
ergosterol composition by disruption of ERG genes, or change in
SL composition by disruption of its biosynthetic genes, leads to
improper surface localization of CaCdr1p [9]. Interestingly, MFS
transporter CaMdr1p shows no such selectivity towards raft lipid
constituents and remains fully membrane localized and functional
in cells where SL or ergosterol biosynthesis is compromised [9].
There are also instances where common regulation of MDR and
lipid metabolism genes have been observed [12,13]. Changes in
the status of membrane lipid phase (or membrane fluidity) and
asymmetry also seem to affect azole resistance in C. albicans [14].
Taken together, MDR in C. albicans is closely linked to the
membrane lipid composition. The overall drug susceptibility of
a cell appears to be an interplay of membrane lipid environment,
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lipids in some way or the other contribute to the development of
resistant phenotype. However, the exact sets of changes that occur
in the lipid composition leading to the resistant phenotype are not
completely understood.
In our previous study, we had used a combination of high
throughput mass spectrometry and statistical validation methods
to analyze the lipidome of eight pairs of genetically matched
clinical azole-susceptible (AS) and azole-resistant (AR) isolates of C.
albicans [16]. We observed that although each AR isolate was
similar with regard to displaying high MICs to drugs, each had
a distinct lipid imprint. That study also revealed that each AR
isolate was rather unique in terms of its lipidome, and that there
were very few common lipid changes among AR isolates. The AS/
AR matched isolates used therein were obtained from different
patients (variable host environment); hence, the typical metabolic
state of each AR isolate was not surprising [16]. In the present
study, we have used a single clinical isolate of C. albicans recovered
from an HIV-patient over a period of 2 years of FLC therapy
during which time the level of FLC tolerance of the strain
increased over 200-fold. Since these isolates were collected from
a single patient, any possibility of variation in host environment
and its effect on metabolic state of cells was minimized. We have
subjected these isolates to high throughput MS-based platform and
have performed detailed lipid profiling and compared the
lipidomes of these sequential isolates of C. albicans. Our study
provides a comprehensive picture of lipidomic changes which
occur as the susceptible isolate develops tolerance to FLC. The
spectrum of about 242 molecular species allowed us to identify and
show how gradually their composition changed with increasing
tolerance to FLC. The changes in ergosterol and SL-components
of membrane microdomains, and in mitochondrial specific lipid
phosphatidyl glycerol (PG) are most noteworthy. Our study shows
an occurrence of a cross-talk between mitochondria, cell wall (CW)
and Candida Drug Resistance (CDR) genes in the clinical scenario,
in a sequential and related C. albicans isolate recovered from a single
patient undergoing azole therapy.
Results
Shotgun screening of Candida Lipidome
The availability of genetically related variants recovered over
a period of time from the same host enabled us to make a direct
comparison of changes in lipidomes occurring in parallel to the
development of resistance to FLC. These 17 isolates (TW1-17)
which have been recovered by White’s group have previously been
characterized to show overexpression of CDR genes associated
with the development of tolerance to FLC [17]. Of note, out of
total isolates, we have chosen 6 isolates from 3 different time points
of FLC therapy to cover the entire range of levels of FLC
tolerance. Based on the MICs, our selection included: TW1 and
TW2 which were highly susceptible to FLC (MIC80 #4mM), TW8
and TW9 had intermediate level of susceptibility to FLC (MIC80
#32mM) while TW16 and TW17 were highly tolerant to FLC
(MIC80 .125mM). Before embarking upon lipidome analysis, we
re-evaluated some of their phenotypic and molecular character-
istics in these selected isolates which matched well with their
published properties (Figure S1). For lipidome analysis, these
selected isolates were harvested in the exponential growth phase
and their total lipids were extracted as described in Materials and
Methods [18]. The extracted lipids were subjected to ESI-MS/MS
by direct infusion of the lipid extracts. The total amount of lipid
was quantified as total normalized mass spectral signal of PGL
(phosphoglycerides) + SL + SE (Sterol ester). The lipid content was
found to range between 1018 to 1136 nmol per mg dry lipid
weight in the Candida isolates analyzed (Sheet S1, worksheet 2).
Although, we determined lipids to their absolute amounts (as
total normalized mass spectral signal of PGL + SL + SE), we have
used the mole percentages (as % of total normalized mass spectral
signal of PGL + SL + SE) for data analysis, which have lower
standard deviation. By employing MS analysis, nine major PGLs
classes which included phosphatidyl choline (PC), phosphatidyl
ethanolamine (PE), phosphatidyl inositol (PI), phosphatidyl serine
(PS), PG, phosphatidic acid (PA), lysoPC, lysoPE and lysoPG were
targeted. Additionally, the lipid molecular species were identified
by mass of the head group plus the mass of the intact lipid,
allowing determination of the number of C atoms and double
bonds in the acyl chain(s) of PGLs. The PGLs were quantified in
relation to internal standards of the same lipid class. This
procedure is known to provide accurate quantification because
various molecular species of the same lipid class (here, the internal
standard and other species) produce very similar amounts of mass
spectral signal after electrospray ionization [19]. Our MS analysis
also included four major groups of SLs, ceramides (CER),
inositolphosphorylceramide (IPC), mannosylinositolphosphoryl-
ceramide (MIPC), mannosyldiinositolphosphorylceramide
(M(IP)2C) and their relative amounts were determined. These
observed lipid differences were also validated by evaluating select
responsible genes of lipid metabolic pathways by reverse
transcriptase PCR (RT-PCR) and by employing high performance
– thin layer chromatography (HP-TLC). Initially, we did perform
RT-PCR of some genes using all the isolates (Figure S1C) and
found that the gene expression pattern was quite similar between
isolate TW16 and TW17, and TW1 and TW2. Therefore for
a direct comparison between most susceptible and tolerant isolate,
RT-PCR was performed only with TW1 and TW17 isolates
(discussed below).
Most tolerant isolates have high levels of sterol esters
Sterols were identified and quantified as SEs, as described in
methods (Text S1). SEs ranged between 2.8 – 15.8% (% of total
normalized mass spectral signal of PGL + SL + SE) which were
accumulated up to 3 folds in TW16 and TW17, as compared to
the less tolerant strain isolated at an earlier time point (Figure 1B).
This accumulation of SEs in TW16 and TW17 was evident by
a simultaneous increase in intermediate metabolites of sterol
biosynthetic pathway and ergosterol ester, which was accumulated
up to ,5 fold (Figure 1A). While examining the FA composition of
SEs, we found that all, C16:1, C16:0, C18:3, C18:2, C18:1 and
C18:0 –FA containing SEs were elevated up to ,4 fold in TW16
and TW17 as compared to the other FLC susceptible isolates
(Sheet S1, worksheet 4). Using RT-PCR, we found that ergosterol
biosynthetic pathway genes are upregulated in TW17 isolate as
compared to susceptible TW1 (Figure 1C). An upregulated ARE2
(an acyl CoA: sterol acyltransferase which regulates free sterol
esterification) correlated well with the fact that most of the sterol
predominantly accumulates as SEs in TW17 isolate (Figure 1C).
Of note, we also noticed an unexplained difference between TW1
and TW2 with regards to the levels of ERG11 expression
(Figure S1C).
MIPC content is depleted in resistant isolates
In C. albicans, it has been demonstrated that the interactions
between membrane SLs and ergosterol are critical, and reduction
in the content of either results in enhanced susceptibilities to drugs
[9–11]. Therefore, to evaluate the impact of FLC exposure on SLs
in TW isolates, we performed a detailed analysis as described in
Text S1. We observed a trend of depletion in SL content in TW17
Lipidome of Candida
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this change was statistically not significant (Figure 2B). Using MS
analysis, we further analyzed four major classes of SLs which
included CER (detected as a-hydroxy phytoceramide), IPC,
MIPC and M(IP)2C (Figure 2A). While the total SLs content did
not vary significantly, MIPC was depleted up to 3.4 folds in TW17
as compared to its susceptible counterparts (Figure 2A). Of note,
though IPC was accumulated by 1.5 fold in TW17 compared to
TW1, but this difference was statistically not significant. M(IP)2C
was below detection limits in TW17 isolate. We validated some of
the genes of SL metabolism by semi-quantitative RT-PCR which
revealed an overexpression of LCB4 (D-erythro-sphingosine
kinase) and ISC1 (inositol phosphosphingolipidphospholipase C);
however, statistically these changes were not significant
(Figure 2C).
Molecular species are responsive to the development of
FLC tolerance
Based on the fatty acid (FA) composition and their positional
distribution, each lipid class is sub-categorized into its molecular
species [20]. A large number of these molecular lipid species and
their numerous interactions with proteins and other lipids in yeasts
provide flexibility in balancing their lipid composition in a variety
of cellular processes [20]. Since majority of the major lipid classes
were not significantly changed in FLC tolerant isolates, we
evaluated that FLC exposure might lead to changes in the content
and composition of different lipid molecular species. Therefore, we
quantified the molecular lipid species by MS analysis of the
extracts of TW isolates and detected molecular lipid species
belonging to three major lipid groups (PGL, SL, and SE; see
Sheet S1, worksheet 2). We could determine the abundance of
over 242 species belonging to PGL, SL and SEs (Table S1 depicts
changes only in the molecular species which were statistically
Figure 1. Upregulation of the sterol biosynthetic pathway in AR isolates. (A) Changes in the composition of major sterols and its
intermediates among the sequential isolates of C. albicans were analyzed as described in methods. Green and black colour of gene in the pathway (A)
represents upregulation and no change, respectively. (B) Total SEs are represented as % of the total PGL+ SE + SL mass spectral signal after
normalization to internal standards and were determined as described in methods. (C) The fold change in gene expression levels of various ERG
genes (relative amplification to ACT1) between TW1 (most susceptible to FLC) and TW17 (most resistant to FLC) were determined by RT-PCR. The gel
picture is a representative of the RT-PCR analysis performed in replicates. Values in the histogram are means 6 SD (n=3 for all Candida strains).
Asterisks ‘‘*’’ represents p,0.05. Lipid data taken from Sheet S1, worksheet 3 and 4.
doi:10.1371/journal.pone.0039812.g001
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FLC concentration, TW isolates show significant differences in the
molecular species composition. For example, when we compared
TW1 vs TW2, TW2 vs TW8, TW8 vs TW9, TW9 vs TW16 and
TW16 vs TW17, the number of molecular species that undergo
a significant change are about 60, 44, 28, 68 and 27, respectively.
When we compared TW1 (most susceptible) with TW17 (most
resistant), about 103 molecular lipid species of different lipid
classes were found to be significantly variable (Sheet S1 (work-
sheet 3) and Table S1).
Notably, the changes in the molecular lipid species were gradual
and correlated with the threshold of FLC tolerance among TW
isolates. That each isolate has a typical molecular species profile
was evident from principal component analysis (PCA) and
hierarchal cluster analysis where these isolates could be separated
as different clusters (Figure S2, Text S2 and Table S5). Moreover,
this large scale lipid remodeling results in higher membrane order
in FLC adapted strains as was evident from fluorescence
polarization studies where TW17 has high P–value and low
unsaturation index (both implying high membrane order) (Figur-
e S3A and S3B).
Long chain FA (LCFA) and odd chain FA levels respond to
the development of FLC tolerance
A thorough examination of the molecular lipid species imprints
of TW isolates revealed that there is accumulation of long chain
FA containing $36-carbon PGL species, and depletion in #34-
carbon containing PGL species with the increasing tolerance to
FLC. This pattern was consistent among all PGL classes, and
reflected FA chain lengths remodeling to maintain membrane
composition in response to FLC stress (Table S2).
We had earlier detected odd chain FA containing lipid species
in various Candida species and in various AS/AR isolates to show
that 31-, 33-, 35- and 37- carbon containing PGL species comprise
the overall pool of the odd chain FAs in Candida [21]. Interestingly,
we observed a depletion of odd chain FA containing PGL species
with increasing tolerance to FLC exposure (Figure 3). These
changes were more prominent in PC, PE, PI and PS species
(Table S3). The large scale compositional changes in FAs of the
PGL species are probably the result of the changes in the gene
expression or changes in the levels of enzymes of FA metabolism
(Table 1).
Mitochondrial PG levels are lower in resistant isolates
Our method could detect six major PGLs in the abundance
order PC.PE.PI.PS.PA.PG, which did not change between
the AS and AR pairs (Figure 4). PC, PE and PI accounted for
almost 80% PGLs in all the isolates. As shown in figure 4 (Inset A),
contents of mitochondrial lipid PG decreased by as much as 1.4
fold in TW17 as compared to most susceptible TW1. However,
MS based lipidome analysis and HP-TLC revealed that there was
no statistically significant change in most of the other PGLs
(Figure 4). PG is metabolic precursor of cardiolipin (CL) which is
a major mitochondrial anionic phospholipid (PL) with important
functions in promoting cell growth, anaerobic metabolism and
mitochondrial biogenesis [22]. We observed that a depletion of PG
Figure 2. Downregulation of the SL biosynthetic pathway in AR isolates. (A) Changes in the composition of major SL classes among the
sequential isolates of C. albicans were assessed as described in methods. Green and black colour of gene in the pathway represents upregulation and
no change, respectively. (B) Total SLs are represented as % of the total PGL + SE + SL mass spectral signal after normalization to internal standards and
were determined as described in methods. (C) The fold change in expression levels of various SL biosynthetic pathway genes (relative amplification to
ACT1) between TW1 (most susceptible to FLC) and TW17 (most resistant to FLC) were determined by RT-PCR. The gel picture is a representative of
the RT-PCR analysis performed in replicates. Values in the histogram are means 6 SD (n=3 for all Candida strains). Asterisks ‘‘*’’ represents p,0.05.
Lipid data taken from Sheet S1, worksheet 4.
doi:10.1371/journal.pone.0039812.g002
Lipidome of Candida
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e39812levels was also associated with a simultaneous decrease in CL levels
(Figure 4, inset B). PGLs composition was also validated by HP-
TLC which showed a drop in PG and CL in most FLC tolerant
TW17 isolate (Figure 4, inset B). It should be noted that we could
only measure CL content by HP-TLC.
However, the RT-PCR data did not show any significant
changes in the transcript levels of CDS1 (a CDP-diglyceride
synthetase) PEL1 (a phosphatidylglycerolphosphate synthase) and
CRD1 (CL synthase) between TW1 and TW17 isolates (Table 1).
Of note, we observed an apparent gradual decrease in CL levels
with increasing FLC tolerance, but the overall ratio of CL/PG was
maintained in most of the isolates. For example, in TW17 the CL
is decreased by ,1.6 fold but the ratio of CL/PG is similar to
TW16 where the contents of CL are rather higher, compared to
TW1 isolate. Apparently, the required CL levels necessary for
proper functioning of mitochondria are largely maintained and it
is the anionic-PG, whose imbalanced level most likely affects the
mitochondrial membrane (discussed below).
Decreased PG level leads to compromised mitochondrial
membrane and CW integrity
We evaluated if reduction in the mitochondrial specific lipid PG
would affect mitochondrial integrity. For this, we used cell-
permeant mitochondrion-selective dye Mito Tracker Red
CMxROS which is a good indicator of mitochondrial integrity
[23,24]. Interestingly, compared to TW1, we observed ,40%
decrease in mean fluorescent intensity in binding of the probe in
TW17 isolate (Figure 5A, 5B and 5C). Of note, no visual
difference in the mitochondrial integrity could be deduced by
confocal microscopy of labeled TW1 and TW17 isolates
(Figure 5D). Moreover, the TW17 did neither show much
alteration in mitochondrial respiratory activity as was deduced
from their ability to grow normally on non-fermentable carbon
sources or at elevated temperatures (data not shown), nor did the
TW17 show any defects in ROS generation as indicated by flow
cytometry and confocal microscopy using DC-FDA (molecular
probes) (data not shown).
The CW integrity is linked to mitochondria and PL homeostasis
[25], however, the link between the mitochondria, CW integrity
and azole resistance is largely unexplored in C. albicans. In-
terestingly, we observed that TW17 isolate was susceptible to the
CW perturbing agents SDS, Congo red and Calcofluor white
(Figure 6A and 6B). The compromised CW integrity of TW17
isolate could further be confirmed by increased passive diffusion
and accumulation of otherwise impermeate fluorescent PI
(Figure 6C and 6D).
A correlation with PG content with CW integrity and
mitochondrial functions was further evident from our other data.
We used two other matched pair clinical isolates of C. albicans,
Gu4/Gu5 and DSY347/DSY289 (where Gu5 and DSY289 are
resistant to drugs). Both Gu5 and DSY289 had lowered PG levels
(,1.5 and ,6.4 fold, respectively) as well as compromised CW as
compared to their susceptible counterparts (Figure 7A and B).
In another matched pair DSY544/DSY775, where the PG
content was higher in resistant DSY775 as compared to its
sensitive counterpart DSY544 (Figure 7B), no CW defect was
evident (Figure 7A). In the DSY294/DSY296 isogenic pair where
PG content did not change between sensitive DSY294 and
resistant DSY296 (Figure 7B) also had no evident CW damage
(Figure 7A). Notably, we could not see consistent differences in the
lipid profiles of these AS and AR pairs (CL levels), probably
because they come from different patients, however, a correlation
with PG content with CW integrity and mitochondrial functions
was further evident from our other data.
Discussion
Prolonged exposure of C. albicans to FLC allows cells to
develop tolerance to higher concentrations of the drug [5–8].
Hence, AR cells display considerably decreased susceptibility to
the drugs (high MICs). An overexpression of efflux pump proteins
like Cdr1, Cdr2, and Mdr1 is one of the main contributors of azole
resistance, which necessitates several compensatory adaptive
changes, that includes alterations in lipid metabolism of Candida
[5–8,12,13,17]. The importance of lipids in the physiology of
Candida including in MDR is well established [9–11,14–16].
However, exactly how lipids adapt or change, are some of the
aspects which are not well understood.
Figure 3. Accumulation of odd chain-FA containing PGLs in the
FLC resistant isolates. Total amount of odd chain FA-containing PGL
was calculated by adding the normalized amounts of each odd chain FA
containing PGL molecular species (namely 31-C, 33-C, 35-C and 37-C
containing PGLs). The data is represented as % of total PGL + SL + SE
mass spectral signal after normalization to internal standards. Values are
mean of 3 independent analyses (n=3). Asterisks ‘‘*’’ represents p ,
0.05. Lipid data taken from Sheet S1 (worksheet 3), Table S1 and
Table S3.
doi:10.1371/journal.pone.0039812.g003
Table 1. Gene expression analysis of various genes between
TW1 and TW17.
Category Gene name TW1 TW17 p-value
PL metabolism PSD1 2.2760.38 3.7460.52 0.07
PSD2 1.4760.15 3.3460.38 0.02
PEL1 1.8060.57 1.8560.65 0.48
CDS1 0.9060.10 0.7860.03 0.11
CRD1 0.8760.08 1.0760.07 0.09
Membrane
pumps
CDR1 1.4560.09 2.4360.16 0.02
CDR2 1.4360.01 2.4460.07 0.00
MDR1 2.2660.11 2.8260.01 0.02
FA metabolism FAS1 0.7060.02 0.7360.03 0.26
FAS2 4.6860.01 5.8960.08 0.00
orf19.6443 1.0960.02 0.9460.04 0.03
EC11 2.7660.11 3.0560.04 0.06
POT1-2 6.8360.18 20.661.00 0.00
orf19.3859 0.9960.07 1.5360.18 0.05
Transcript levels were determined by RT-PCR as described in Methods. The data
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lipid regulatory circuitry behind MDR in C. albicans, we had
performed a comparative lipidomics of AS and AR clinical isolates
of C. albicans isolated from different patients [16]. In the present
study, to minimize any variations due to host/pathogen niches, we
have used sequential isolates earlier isolated by Ted White’s group,
from a single HIV-infected patient who was on FLC therapy for
over a period of 2 years [17]. In this TW series of 17 isolates
(TW1-17), each isolate represents an isogenic precursor parent of
the next isolate. A comparative snap shot lipidomic status of
selected sequential AR isolates of C. albicans gave interesting
insights.
Membrane raft specific lipids are selectively affected in
AR isolates
In C. albicans, ergosterol which is predominantly localized within
microdomains ‘‘lipid raft’’, is involved in many physiological
functions and provides surface localization platform for membrane
proteins [9–11,26,27]. Thus, the observed raised levels of
ergosterol in highly resistant TW16 and 17 (validated by RT-
PCR) (Figure 1) could be linked to an overexpressed level of Cdr1
protein, since it is preferentially localized within the lipid raft
microdomains [9]. Recently, Zhang et al. demonstrated that
ergosterol levels are required in V-ATPase function which forms
the cellular basis of azole toxicity in C. albicans [28]. Further, the
mammalian presynaptic serotonin transporter (SERT) is function-
ally overexpressed only in the presence of cholesterol [29].
In contrast to ergosterol, there was a marked depletion of
another major constituent of membrane microdomains. One of
the complex SL members, MIPC contents was significantly lower
in TW16/17 isolate as compared to TW1 (Figure 2A). This
depletion in MIPC content may appear odd for maintenance of
the raft domain. However, there are instances to show that
a minimum level of SL is sufficient to maintain the raft integrity
and efflux function [30]. Therefore, it could be argued that
observed depletion of SLs which is probably the result of azoles
induced compensatory changes in TW17 remains within its critical
limits and along with the raised ergosterol, continues to provide
optimal platform to maintain the functionality of overproduced
Cdr1 protein.
Azole resistance necessitates remodeling of molecular
species of lipids
In yeasts, although structural classes of lipids are limited, they
have the potential to generate up to several thousand different
molecular species to bring in diversity in lipid composition [20].
Our present results clearly demonstrate that exposure of C. albicans
to FLC triggers massive remodeling of molecular lipid species in
TW isolates (Table S1, Sheet S1, worksheet 2 and 3). The fact
that ,103 molecular lipid species were found to be significantly
variable between TW1 and TW17 implies that there is large scale
remodeling of molecular lipid species while the isolate gradually
adapts to FLC toxicity. Since the intracellular drug concentration
is dependent not only on active drug efflux, but also on the rate of
its import, the order of the membrane lipid bilayer core becomes
an important determinant in the development of drug resistance
[14,15,26].
Figure 4. The sequential isolates of C. albicans shows modulation of PGL metabolism in the AR isolates. Changes in the composition of
major SL classes among the sequential isolates of C. albicans were assessed as described in methods. Data is represented as % of the total PGL+ SE +
SL mass spectral signal after normalization to internal standards. Inset A depicts in larger scale, the change in PG levels among the sequential isolates
of C. albicans. Values are mean of 3 independent analyses (n=3). Data taken from Sheet S1, worksheet 4. Inset B shows PL analysis of strains by HP-
TLC: cells were grown overnight (to the exponential growth phase) in YEPD medium. Lipids were extracted as described earlier [18] and separated by
thin-layer chromatography using chloroform: methanol: acetic acid (65:28:8) as the solvent system. The mobility of CL, PA, PG, PE, PS, PI and PC are
indicated after iodine staining (n=2). The corresponding values of each lipid class as mol % are also indicated.
doi:10.1371/journal.pone.0039812.g004
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odd chain FAs
The LCFA’s are functionally very relevant in bacterial models
but in yeasts like C. albicans these are poorly understood [21,31,32].
In C. albicans, it is quite understandable that the membrane PLs
might incorporate FAs of varying length and saturation to
maintain the optimal membrane order [33]. Precisely, we
observed an accumulation of LCFA containing $36-carbon
PGL species at an expense of #34-carbon containing PGL
species, with the increasing FLC tolerance (Table S2). Since the
FAs with lesser chain lengths, and higher unsaturation are less
rigid [34], therefore an increased pool of LCFA (of $36-carbon
containing PGLs) might directly be contributing to maintain the
high order of the membrane.
Notably, we also observed a progressive depletion of typical odd
chain FA containing PGLs with the increasing tolerance to FLC
(Figure 3 and Table S3). Although this study for the first time
points towards odd chain FA containing PGLs role in drug
tolerance adapting mechanisms of pathogenic C. albicans, a com-
plete understanding of the physiological relevance of it requires
further validation. If explored in detail, possibly like in animal
models of environmental and food web studies, these odd chain
FAs could serve as useful biomarkers for C. albicans drug resistance
[35–37].
Together, changes like increased pool of LCFA’s and depletion
of odd-chain FAs along with variations in molecular lipid species
are the reflection of close knit maintenance of membrane lipid
homeostasis. Of note, the fact that both odd chain FAs and very-
LCFA (generally up to 22 carbons) are well established features of
plant lipids [36,38], the presence of these lipids in human
pathogenic C. albicans is of great evolutionary significance [21].
A change in PG and CL in AR isolates points a link
between mitochondria and CW integrity
Recently, mitochondria have been identified as an important
contributor to virulence and drug tolerance of human fungal
pathogens [39–43]. For example, mitochondrial mutants of yeast
display altered drug susceptibility to drugs, particularly those
which target cell membranes, such as the azoles and the polyenes
[25,41,43,44–47]. Apparently mitochondrial function in mem-
Figure 5. Measurement of mitochondrial membrane dysfunction among TW1 and TW17 isolates. For the flow cytometry analysis, cells
were stained with 100 nM MitoTracker Red CMXRos (which fluoresces upon oxidation in respiring mitochondria). (A) Quadrant plots, (B) histograms
and (C) bar graph of flow cytometry analysis between TW1 and TW17 are depicted (n=4). (D) The red fluorescence of MitoTracker Red CMXRos was
also visualized by confocal microscopy.
doi:10.1371/journal.pone.0039812.g005
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39812Figure 6. FLC exposure alters CW integrity in the sequential isolates of C. albicans. (A) Sequential isolates were tested with CW perturbing
agents like Triton X-100 (upto 0.04%), 0.02% SDS, 16 mgml
21 Congo Red. (B) Susceptibility to Calcofluor White (upto 50 mgml
21) was tested. These
spot tests were performed as described in methods. (C) Passive diffusion rate of PI was monitored by spectrofluorimeter. Briefly, the cells were pre-
incubated with 3 mM PI for 45 min and then centrifuged. The supernatant was taken and the emission spectrum of PI was recorded for each strain.
(D) The cells with PI were subjected to flow cytometry analysis to measure the amount of PI accumulated in each strain. The data is represented as
the mean fluorescent intensity (n=2).
doi:10.1371/journal.pone.0039812.g006
Figure 7. FLC exposure leads to gradual development of a partially compromised CW and affects PG biosynthesis in several other
clinical isolates of C. albicans. A. Several pairs of isogenic clinical isolates of C. albicans were tested with 0.02% SDS, a CW perturbing agent. The
spot tests were performed as described in methods. B. PL analysis of various AS/AR clinically matched isogenic isolates by HP-TLC. Briefly, cells were
grown overnight (to the exponential growth phase) in YEPD medium. Lipids were extracted as described earlier [18] and separated by thin-layer
chromatography using chloroform: methanol: acetic acid (65:28:8) as the solvent system. HP-TLC analysis of each match pair and the corresponding
values of each lipid class as mol % are also indicated.
doi:10.1371/journal.pone.0039812.g007
Lipidome of Candida
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e39812brane lipid homeostasis is the common denominator underlying
the observed effects of mitochondria in drug tolerance and CW
integrity. The mechanistic details, particularly how these two
pathways are linked, are far from understood. The observed
changes in the levels of mitochondrial lipid PG led us to speculate
if mitochondrial function is compromised in these isolates.
Notably, a decrease accessibility of mito-tracker dye to TW17
cells as compared to TW1 cells provided sufficient evidence of
compromised mitochondria (Figure 5); however, apparently the
damage was restricted to mitochondrial membrane structure since
it was not enough to cause respiratory defect and the accumulation
of ROS (data not shown). This also supports an earlier observation
that respiratory deficiency per se is not sufficient for eliciting MDR
in yeast [43,47].
There are examples to suggest a possible link between
mitochondrial dysfunction, lipid homeostasis and CW integrity
[25,48]. Reportedly, S. cerevisiae and C. glabrata mitochondrial
mutants most susceptible to caspofungin were those with impaired
mitochondrial biosynthesis of the PLs namely PG and CL
[25,43,49–51]. We observed that AR isolate TW17 that had
lower levels of PG also possessed damaged CW as was evident
from its sensitivity to CW disrupting agents and TEM images.
Notably, we could also indirectly correlate CW damage and azole
resistance with mitochondrial PG content by assessing CW
damage in another set of matched pairs of AS and AR isolates.
We observed that AR isolates which had lower PG content were
also susceptible to CW disrupting agents as compared to those
pairs which were resistant to azoles but showed no change in PG
levels. We suspect that it is PG levels rather than CL that are more
linked to mitochondrial defect and CW integrity. This notion is
supported by a recent study, where it is demonstrated that nulls of
PEL1 (encodes PG biosynthetic gene) in C. albicans have damaged
CW and decreased susceptibility to FLC [52]. Notably, CL defects
in mitochondrial membranes can easily be compensated for by PE,
with the two PLs having overlapping roles [53–55]. Our MS and
HP-TLC did not reveal any significant change in PE levels
between these isolates (Figure 4). However, this was not reflected
from our RT-PCR data analysis where both PSD1 and PSD2 (the
phosphatidylserine decarboxylases that catalyze the conversion of
PS to PE) were upregulated in TW17 isolate as compared with its
susceptible counterpart (Table 1).
Notably, in certain matched clinical isolates (DSY775/DSY296)
neither PG levels nor any defect in CW integrity was evident and
yet these isolates displayed reduce susceptibility to FLC. It
emphasizes the fact that that the development of MDR in C.
albicans employs multiple pathways [5–8].
Although our data establishes a link between altered lipid
homeostasis, mitochondrial dysfunction and CW integrity in the
development of azole tolerance in C. albicans, how these events lead
to the activation of MDR pathway is not clear. It has been shown
that mitochondrial dysfunction can lead to the activation of Pdr
pathway in S. cerevisiae [56]. The available evidence in S. cerevisiae
points to a link between mitochondrial control over membrane
structure and lipid homeostasis and the role of the Pdr pathway in
membrane biogenesis [43,57–59]. For example, deletion of
ScOXA1 (a mitochondrial inner membrane insertase with cyto-
chrome oxidase activity) results in increase drug resistance without
any apparent loss in mtDNA [47,59]. Loss of PGS1 (a
phosphatidylglycerolphosphate synthase that catalyzes the synthe-
sis of phosphatidylglycerolphosphate from CDP-diacylglycerol and
sn-glycerol 3-phosphate) also results in decrease susceptibility to
drugs independent of mtDNA loss [39,57–61]. It is shown that in
Psd1 in respiratory deficient yeast is partly dissociated and results
in activation of MDR pathway [43,62]. However, one needs to
uncover regulatory pathway (s) interlinking CDR genes with
mitochondrial functions in C. albicans.
Although it is not yet clear how and in which order these events
are interlinked and triggered, but one could safely conclude that
an extensive membrane remodeling and cellular lipid signaling is
essential for the survival of azole stress and for the up-regulation of
genes coding for multidrug transporters. Several recent studies
have highlighted the importance of mitochondrial function for
tolerance of antifungal drugs but the exact molecular mechanisms
are not fully understood. Our study provides first clinical evidence
wherein an interplay between mitochondria, CW and lipid
homeostasis in the development of azole tolerance is evident.
Materials and Methods
Strains, media and culture conditions
C. albicans strains used in this study are listed in Table S4
[16,17,67,68] and will be described as TW series of isolates
throughout the study. C. albicans cells were kept on YPD plates and
used to inoculate in YPD medium (1% yeast extract, 2% glucose,
and 2% bactopeptone). For solid media, 2.5% agar was added.
The cells were diluted into 50 ml fresh medium at 0.1 OD at A600
(,10
6 cells/ml) and grown until the cells reached the density of
,2610
8 cells/ml at 30uC (approximately in 14 hrs). Three
separate cultures of each Candida isolate were used.
Lipid standards
Synthetic lipids with FA compositions that are not found, or are
of very low abundance in Candida, were used as internal standards.
Lipid standards were obtained from Avanti Polar Lipids (Alabas-
ter, AL).
Lipid Extraction
Lipids were extracted from Candida cells using a slight modifi-
cation of the method of Bligh and Dyer [18]. Briefly, the Candida
cells were harvested at exponential phase and were suspended in
10 ml methanol. 4 g glass beads (Glaperlon 0.40–0.60 mm) were
added and the suspension was shaken in a cell disintegrator (B.
Braun, Melsungen, Germany) four times for 30 sec with a gap of
30 sec between shakings. Approximately 20 ml chloroform was
added to the suspension to give a ratio of 2:1 of chloroform:
methanol (v/v). The suspension was stirred on a flat-bed stirrer at
room temperature for 2 hrs and then filtered through Whatman
No. 1 filter paper. The extract was then transferred to a separating
funnel and washed with 0.2 volumes of 0.9% NaCl to remove the
non-lipid contaminants. The aqueous layer was aspirated and the
solvent of the lipid-containing, lower organic layer was evaporated
under N2. The lipids were stored at 280uC until they were
analyzed.
ESI-MS/MS lipid profiling
An automated ESI-MS/MS approach was used to quantify
PGL, SL and SE. Data acquisition and analysis was carried out as
described previously by Devaiah et al. and Singh et al. [16,26,63].
Precise amounts of internal standards, obtained and quantified as
previously described by Welti et al. and Singh et al. [16,26,64],
were added. Processing of the data, including isotope deconvolu-
tion, was done similar to the way described by Singh et al. [16,21].
For details, see Text S1.
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TLC)
The Candida cells were grown overnight (to the exponential
growth phase) in YEPD medium. Lipids were extracted as
described earlier [18]. Following extraction samples were
processed on the automated HP-TLC system (CAMAG, Muttenz,
Switzerland) according to the instructions of the manufacturer.
Ready-to-use silica coated plates (Merck) were activated in 80uC
for 30–45 min. Sample volume equivalent to 120mg lipid was
applied in band-form using specialized Hamilton syringe on one-
side of the TLC plate in individual tracks. The TLC plate was
developed in chloroform: methanol: acetic acid (65:28:8) solvent
system. The plate was developed in the automated developing
chamber (CAMAG) until the solvent front reached the maximum
distance (80 mm distance in a typical 20610 cm plate). The
developed plate was dried and separated lipids were stained with
iodine for visualization of various PLs. Then subsequent charring
with 470 mM CuSO4 (in 8.5% o-phosphoric acid) was carried out.
The individual Rf values of peaks along with their peak areas were
obtained. These data were matched with the lipid standards.
Drug susceptibility
Drug susceptibilities were measured by using microtiter plate
and spot assays. The MICs for the strains were determined with
a broth microdilution method as described previously [15]. For the
spot assay, 5-ml samples of fivefold serial dilutions of each yeast
culture (each with cells suspended in normal saline to an optical
density at 600 nm [OD600] of 0.1) were spotted onto YEPD plates
in the absence (control) or in the presence of various concentra-
tions of FLC. Growth differences were recorded following
incubation of the plates for 48 h at 30uC.
Mitochondrial integrity
The integrity of mitochondria was determined using Mito-
Tracker Red CMXRos (Molecular probes, Invitrogen). Briefly,
cells (equal to 0.1 O.D) were stained with 100 nM MitoTracker
Red CMXRos (which fluoresces upon oxidation in respiring
mitochondria) at 30uC for 45 min. Flow cytometry of the stained
cells was performed as described previously [23]. The red
fluorescence of MitoTracker Red CMXRos was also visualized
by confocal microscopy as described previously [23,24].
CW susceptibility
Spot tests were performed (as described above) on YEPD plates
in the absence (control) or in the presence of the following agents:
SDS (0.02%), congo red (16 mg/ml) and calcofluor white (upto
50 mg/ml). The plates then incubated for 48 hrs at 30uC, recorded
growth differences.
Membrane permeabilization assays
The permeability changes in Candida isolates was monitored by
the impermeant dye PI (Propiduim Iodide). For this, C. albicans
cells (,1610
6) were first harvested at the logarithmic phase and
suspended in PBS (phosphate buffer saline). Cells were incubated
in water bath set at 30uC at 200 rpm with 3.0 mM (PI) for 45 min.
After incubation, cells were harvested by centrifugation. The
aliquots of the cell suspension were taken in separate vials and then
cells were re-suspended in PBS [65]. Flow cytometry was
performed with a Calibur flow cytometer (Becton–Dickinson,
San Jose, CA, USA). Further, the aliquots after PI treatments
(those collected in flow cytometry experiment) were taken and the
emission spectrum of PI was recorded for each strain using
a fluorescence spectrophotometer (CARY-Eclipse, Varian Inc.,
Netherlands). The excitation and emission wavelengths used for PI
were 536 and 617 nm respectively.
Reverse transcriptase – polymerase chain reaction (RT-
PCR)
RNA isolation was done using RNeasy Mini Kit (QIAGEN
Inc., USA) as per manufacturer’s specifications, except that 300ml
acid washed 0.4–0.6 mm glass beads (Sigma, St. Louis, MO) were
used during cell lysis. RNA was precipitated using absolute ethanol
and washed twice with 80% ethanol, dried and resuspended in
50 ml DEPC treated water at 58
oC. RNA obtained was
quantitated spectrophometrically and it was also electrophoresed
in denaturing formaldehyde gel.
RT-PCR was done using the RevertAid
TM H Minus kit (MBI,
Fermentas). Briefly, 1mg isolated RNA was primed with oligo
(dT)18 for cDNA syntheis at 42uC for 60 min. Reverse transcrip-
tion reaction was terminated by heating at 70uC for 5 min. The
synthesized cDNA product (2ml) was directly used for PCR
amplification reaction (50 ml) using gene specific forward and
reverse primers. The amplified products were subjected to gel
electrophoresis and were quantitated by using Quantity One
software with the Bio-Rad gel documentation system. The
densities of bands (for genes of interest) were measured and
normalized to that of the endogenous gene. The oligonucleotide
sequences used for RT-PCR are listed in Sheet S2. Of note, our
RT-PCR analysis included most of the responsive genes of lipid
metabolism as was earlier detected from the microarray analysis of
these isolates [66].
Statistical Analysis
The mean of three independent biological replicates 6 standard
deviation (SD) from the individual samples was used to compare
the lipids of Candida strains. Multivariate data analysis (pattern
recognition) was employed. PCA was performed using the software
SYSTAT, version 10 (Systat Software Inc., Richmond, CA, USA)
using three replicates of each of the AS and AR Candida isolate to
highlight the statistically significant lipid differences. To assess the
statistical significance of the difference in lipid datasets and PC
scores, the Student t-test was performed using the significance level
of 0.05. Hierarchical cluster analysis was also performed using
SYSTAT, version 10. When all the values for a particular lipid
species were zero in all samples, the data for that lipid species were
removed from the analysis. The data in percentage were log-
transformed and normalized to the same scale for PCA and
hierarchical cluster analysis.
Supporting Information
Figure S1 Phenotypic and molecular properties of the
sequential isolates of C. albicans used in this study.
Isolates are shown on the y axis in the order in which they were
obtained from the patient. MICs of FLC were determined by (A)
liquid FLC susceptibility assay and (B) the spot assay, as described
in Methods. Approximate numbers of cells (per ml) are indicated
at the top of panel B. MICs are reported as MIC80 (mM). (C)
Genetic changes were identified as the gene expression levels of
CDR1, MDR1 and ERG genes as determined by RT-PCR,
described in Methods. Values shown as MICs are mean of 3
independent analyses. Spots and RT-PCR result was repeatable at
least in 2 independent analyses.
(TIF)
Figure S2 Principal component analysis (PCA) and
hierarchical cluster analysis of lipid species amongst
Lipidome of Candida
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using the software SYSTAT, version 10 as described in Text S2.
The scores for the first three principal components, explaining
53% of the variance, were plotted. Each point in the plot is the
mean of corresponding replicate’s principal component scores. (A)
The scores plot of principal component 1 (27.4% of variance) vs
principal component 2 (15.2%). (B) The scores plot of principal
component 1 (27.4%) vs principal component 3 (10.8% of
variance). (C) Hierarchical cluster dendrogram was prepared
using lipidome profiles of the TW isolates. Hierarchical clustering
was performed using the software SYSTAT, version 10 as
described in Text S2.
(TIF)
Figure S3 Membrane fluidity and unsaturation index
measurements in the sequential isolates of C. albicans.
(A) Membrane fluidity was assessed in terms of fluorescence
polarization measurements, which were carried out using
fluorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH), as a re-
porter. Briey, cells were incubated with Zymolyase (100 U/g wet
weight) at 37uC for 3 h with gentle shaking to remove the CW.
Spheroplast preparation was monitored turbidometrically by
checking the ability of 0.2% sodium dodecyl sulfate to lyse the
enzyme-digested cells. Fluorescence polarization was measured at
excitation and emission wavelengths of 360 and 426 nm, re-
spectively. The measured uorescence intensities were corrected for
background uorescence and the light scattering from the unlabeled
sample. (B) Degree of unsaturation was determined by calculating
the unsaturation index (UI) of the PGLs. UI was calculated as
follows: UI = [(1 x % monoene-PGL) + (1 x % diene-PGL) + (1 x
% triene-PGL) + (1 x % triene-PGL) + (1 x % tetraene-PGL) + (1 x
% pentaene-PGL) + (1 x % hexaene-PGL)]/100. Values are mean
of 3 independent analyses (n=3). Asterisks ‘‘*’’ represents p,0.05.
Lipid data taken from Sheet S1, worksheet 3.
(TIF)
Sheet S1 Lipid amounts of lipid classes and molecular
species. Worksheet 1 is the information sheet. Worksheet 2 has
the absolute amounts (nmol per mg dry lipid wt.) of the molecular
lipid species. Worksheet 3 has the mol percentages (% total mass
spectral signal of PGL + SL + SE) of the molecular lipid species.
Worksheet 4 the total amounts of various lipid classes as the mol
percentages (% total mass spectral signal of PGL + SL + SE).
(XLS)
Sheet S2 Oligonucleotides used in this study for RT-
PCR.
(XLS)
Table S1 Changes in molecular lipid species upon FLC
stress. Blue and Red colours represent decreasing and
increasing trends respectively. The length of the colour in
each cell represents the predominance of a lipid species. A total of
242 lipid species were detected, however, table depicts only those
lipid species which showed differences between TW1 and TW17
with p-values ,0.05. Values are represented as % of the total PGL
+ SE + SL mass spectral signal and the data taken from Sheet S1,
worksheet 3.
(DOC)
Table S2 Abundance of PGLs based on their total
number of carbons in the FA chains among various
isolates used in this study. The data is represented as % of
total PGL + SL + SE mass spectral signal after normalization to
internal standards. Values are mean of 3 independent analyses
(n=3). Asterisks ‘‘*’’ represents p,0.05. Data taken from Sheet
S1, worksheet 3.
(DOC)
Table S3 Changes in the contents of odd chain FA –
containing PGL classes among various isolates used in
this study. Total amount of odd chain FA-containing PGLs for
each lipid class was calculated by adding the normalized amounts
of each odd chain FA -containing PGL molecular species of that
particular class (namely 31-C, 33-C, 35-C and 37-C containing
PGLs). Odd chain FA -containing lipid species were not detected
in PA class. The data is represented as % of total PGL + SL + SE
mass spectral signal after normalization to internal standards.
Values are mean of 3 independent analyses (n=3). Asterisks ‘‘*’’
represents p,0.05. Data taken from Sheet S1, worksheet 3.
(DOC)
Table S4 Strains used in the study.
(DOC)
Table S5 Loadings of principal components 1, 2 and 3.
The 12 highest and 12 lowest values are indicated. In red colour
are shown the molecular lipids species that match with our
previous prediction of molecular species that are more responsive
during the azole stress [16].
(DOC)
Text S1 ESI-MS/MS lipid profiling.
(DOC)
Text S2 Principal Component Analysis (PCA) and
Hierarchal cluster analysis of lipid species quantitative
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